Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Prednisone
Related studies linked through entity extraction aliases.
Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial
- Status
- RECRUITING
- Phase
- PHASE2
A Phase II Trial of 4 vs 6 Cycles of CHP Combined With Polatuzumab Vedotin-Rituximab in Untreated DLBCL Patients With IPI 0-1
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Safe Effective Therapy With Low-Dose Glucocorticoid in ANCA-Associated Vasculitis (SAFE-LOW)
- Status
- RECRUITING
- Phase
- PHASE3
Loncastuximab and Roflumilast Added to R-CHOP (Lo-(Rituximab and Roflumilast) RR-CHOP) for Naïve High-Risk Diffuse Large B-cell Lymphoma (DLBCL)
- Status
- RECRUITING
- Phase
- PHASE1
Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)
- Status
- RECRUITING
- Phase
- PHASE2
Prednisone in Adults With an Immune-Mediated Subtype of Autism Spectrum Disorder
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- Status
- RECRUITING
- Phase
- PHASE3
Efficacy of Human Chorionic Gonadotropin in Acute GVHD Treatment
- Status
- RECRUITING
- Phase
- PHASE2
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate Opevesostat (MK-5684) in Male Participants With Moderate Hepatic Impairment (MK-5684-009)
- Status
- COMPLETED
- Phase
- PHASE1
DOSE Trial: Optimal Dose of Oral Corticosteroids to Treat Asthma Exacerbations
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Treatment for Giant Cell Arteritis With Tocilizumab and 8 as Compared to 26 Weeks of Prednisone
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Study to Evaluate the Effect of MK-5684 in Male Participants With Severe Renal Impairment (RI) and With End-stage Renal Disease (ESRD) (MK-5684-010)
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Pola-RCHP-X vs Pola-RCHP in Untreated DLBCL
- Status
- RECRUITING
- Phase
- PHASE2
Randomized Controlled Trial of Mycophenolate Mofetil Versus Steroid Therapy in Alcoholic Hepatitis
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Comparing the Therapeutic Effects of Using Ruxolitinib and Steroids Concurrently to Steroids Alone as Initial Treatment In Patients Diagnosed With Chronic Graft-versus-host Disease at a Grade of Moderate or Higher Severity
- Status
- RECRUITING
- Phase
- PHASE2
Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- PHASE2